Diabetes, Vol 36, Issue 11 1286-1291, Copyright © 1987 by American Diabetes Association

ARTICLES

Competitive insulin autoantibody assay. Prospective evaluation of subjects at high risk for development of type I diabetes mellitus

P Vardi, SA Dib, M Tuttleman, JE Connelly, M Grinbergs, A Radizabeh, WJ Riley, NK Maclaren, GS Eisenbarth and JS Soeldner
Research Division, the Joslin Diabetes Center, Boston, MA 02215.

A quantitative fluid-phase radioassay for autoantibodies reacting with insulin (competitive insulin autoantibody assay, CIAA) was developed. The assay's features include 1) use of a physiologic amount of 125I-labeled insulin, 2) parallel incubations with supraphysiologic cold insulin (competitive), and 3) an incubation time of 7 days and a single-step multiple-wash polyethylene glycol separation. Mean +/- SE CIAA levels in 50 controls were 8 +/- 1.4 nU/ml (range -16-33.3). In 36 cytoplasmic islet cell antibody (ICA)-positive nondiabetic first-degree relatives of type I (insulin-dependent) patients less than 30 yr of age, CIAA levels exceeded the normal range in 20 (55.6%) of 36 (mean 86.8 +/- 17.1 nU/ml). In 26 ICA-positive relatives greater than 30 yr of age, only 5 (19.2%) of 26 exceeded the normal range (mean 26.1 +/- 9.4 nU/ml); P less than .001 compared with younger ICA-positive relatives). Six ICA-negative HLA-identical siblings of type I diabetic patients had normal CIAA levels (mean 3.6 +/- 5.8 nU/ml), and only 2 of 13 ICA-negative identical twins discordant for diabetes (mean 15.4 +/- 6.6 nU/ml) exceeded the normal range. Nine (50%) of 18 ICA-positive schoolchildren exceeded the normal range (mean 105.3 +/- 36.7 nU/ml). Genetically susceptible subjects negative for CIAA (with only 3 exceptions) remained negative for CIAA on multiple determinations (3 conversions observed), and CIAA levels of positive subjects were relatively stable. Linear regression of the first CIAA level versus last (interval between sampling 1 mo to 10 yr) in genetically susceptible individuals showed a highly significant correlation (r = .95, P less than .001).(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. Kis, P. Engelmann, K. Farkas, G. Richman, S. Eck, J. Lolley, H. Jalahej, M. Borowiec, S. C. Kent, A. Treszl, et al. Reduced CD4+ subset and Th1 bias of the human iNKT cells in Type 1 diabetes mellitus J. Leukoc. Biol., March 1, 2007; 81(3): 654 - 662. [Abstract] [Full Text] [PDF]

				J. M. Sosenko, J. P. Palmer, C. J. Greenbaum, J. Mahon, C. Cowie, J. P. Krischer, H. P. Chase, N. H. White, B. Buckingham, K. C. Herold, et al. Patterns of metabolic progression to type 1 diabetes in the diabetes prevention trial-type 1. Diabetes Care, March 1, 2006; 29(3): 643 - 649. [Abstract] [Full Text] [PDF]

				J. P. Krischer, D. D. Cuthbertson, and C. Greenbaum Male Sex Increases the Risk of Autoimmunity but not Type 1 Diabetes Diabetes Care, August 1, 2004; 27(8): 1985 - 1990. [Abstract] [Full Text] [PDF]

				P. J. Bingley, E. Bonifacio, and P. W. Mueller Diabetes Antibody Standardization Program: First Assay Proficiency Evaluation Diabetes, May 1, 2003; 52(5): 1128 - 1136. [Abstract] [Full Text] [PDF]

				J. P. Krischer, D. D. Cuthbertson, L. Yu, T. Orban, N. Maclaren, R. Jackson, W. E. Winter, D. A. Schatz, J. P. Palmer, and G. S. Eisenbarth Screening Strategies for the Identification of Multiple Antibody-Positive Relatives of Individuals with Type 1 Diabetes J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 103 - 108. [Abstract] [Full Text] [PDF]

				Diabetes Prevention Trial-Type 1 Diabetes Study Gr Effects of Insulin in Relatives of Patients with Type 1 Diabetes Mellitus N. Engl. J. Med., May 30, 2002; 346(22): 1685 - 1691. [Abstract] [Full Text] [PDF]

				W. S. Cutfield, P. L. Hofman, M. Vickers, B. Breier, W. F. Blum, and E. M. Robinson IGFs and Binding Proteins in Short Children with Intrauterine Growth Retardation J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 235 - 239. [Abstract] [Full Text] [PDF]

				A. Zeidler, L. J. Raffel, G. Costin, S. J. Shaw, T. A. Buchanan, J. Noble, J. I. Rotter, J. Palmer, J. P. Krischer, C. Wait, et al. Autoantibodies and Human Leucocyte Antigen Class II in First-Degree Family Members of Mexican-American Type 1 Diabetic Patients J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4957 - 4962. [Abstract] [Full Text] [PDF]

				L. Yu, D. D. Cuthbertson, N. Maclaren, R. Jackson, J. P. Palmer, T. Orban, G. S. Eisenbarth, and J. P. Krischer Expression of GAD65 and Islet Cell Antibody (ICA512) Autoantibodies Among Cytoplasmic ICA+ Relatives Is Associated With Eligibility for the Diabetes Prevention Trial-Type 1 Diabetes, August 1, 2001; 50(8): 1735 - 1740. [Abstract] [Full Text] [PDF]

				J. Yu, L. Yu, T. L. Bugawan, H. A. Erlich, K. Barriga, M. Hoffman, M. Rewers, and G. S. Eisenbarth Transient Antiislet Autoantibodies: Infrequent Occurrence and Lack of Association with "Genetic" Risk Factors J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2421 - 2428. [Abstract] [Full Text]

				A. Imagawa, T. Hanafusa, J.-i. Miyagawa, Y. Matsuzawa, and The Osaka IDDM Study Group A Novel Subtype of Type 1 Diabetes Mellitus Characterized by a Rapid Onset and an Absence of Diabetes-Related Antibodies N. Engl. J. Med., February 3, 2000; 342(5): 301 - 307. [Abstract] [Full Text] [PDF]

				A. Pugliese, E. Kawasaki, M. Zeller, L. Yu, S. Babu, M. Solimena, C. T. Moraes, M. Pietropaolo, R. P. Friday, M. Trucco, et al. Sequence Analysis of the Diabetes-Protective Human Leukocyte Antigen-DQB10602 Allele in Unaffected, Islet Cell Antibody-Positive First Degree Relatives and in Rare Patients with Type 1 Diabetes J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1722 - 1728. [Abstract] [Full Text]

				H. E. Naserke, E. Bonifacio, and A.-G. Ziegler Immunoglobulin G Insulin Autoantibodies in BABYDIAB Offspring Appear Postnatally: Sensitive Early Detection Using a Protein A/G-Based Radiobinding Assay J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1239 - 1243. [Abstract] [Full Text]

				R. H. Slover and G. S. Eisenbarth Prevention of Type I Diabetes and Recurrent {beta}-Cell Destruction of Transplanted Islets Endocr. Rev., April 1, 1997; 18(2): 241 - 258. [Abstract] [Full Text]

				E. Kawasaki, L. Yu, R. Gianani, C. F. Verge, S. Babu, E. Bonifacio, and G. S. Eisenbarth Evaluation of Islet Cell Antigen (ICA) 512/IA-2 Autoantibody Radioassays Using Overlapping ICA512/IA-2 Constructs J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 375 - 380. [Abstract] [Full Text] [PDF]

				P. L. Hofman, W. S. Cutfield, E. M. Robinson, R. N. Bergman, R. K. Menon, M. A. Sperling, and P. D. Gluckman Insulin Resistance in Short Children with Intrauterine Growth Retardation J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 402 - 406. [Abstract] [Full Text] [PDF]

				M. A. Atkinson and N. K. Maclaren The Pathogenesis of Insulin-Dependent Diabetes Mellitus N. Engl. J. Med., November 24, 1994; 331(21): 1428 - 1436. [Full Text]

				D Faustman, X. Li, H. Lin, Y. Fu, G Eisenbarth, J Avruch, and J Guo Linkage of faulty major histocompatibility complex class I to autoimmune diabetes Science, December 20, 1991; 254(5039): 1756 - 1761. [Abstract] [PDF]

				L. Yu, D. T. Robles, N. Abiru, P. Kaur, M. Rewers, K. Kelemen, and G. S. Eisenbarth Early expression of antiinsulin autoantibodies of humans and the NOD mouse: Evidence for early determination of subsequent diabetes PNAS, February 15, 2000; 97(4): 1701 - 1706. [Abstract] [Full Text] [PDF]